Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study

Documenti analoghi

• Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
  di: Eisenberger, Ute, et al.
  Pubblicazione: (2018)
• Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial
  di: Budde, Klemens, et al.
  Pubblicazione: (2017)
• Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy
  di: Sommerer, Claudia, et al.
  Pubblicazione: (2018)
• Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3‐year results from the randomized ZEUS study
  di: Budde, Klemens, et al.
  Pubblicazione: (2012)
• Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial
  di: Sommerer, Claudia, et al.
  Pubblicazione: (2016)